RxDoctor Payments Data

Anita Williams

Gerontology · Tulsa, OKNPI 1417356791

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Global Blood Therapeutics, Inc. at 43.1% of the total. Reporting peaked in 2022 at $344 and has fallen 82.7% since, to $60 in 2025. That places this record below the midpoint for gerontology clinicians in OK, where the typical reported total is $938.

$645in general payments, 2019–2025

Across 26 payments — averaging $24.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Global Blood Therapeutics, Inc.$278
  • Pharmacosmos Therapeutics Inc.$189
  • Johnson & Johnson$47
  • Exact Sciences$41
  • Pfizer$33
  • Medtronic$23
  • plus $34 from 2 others

What the payments were for

  • Food & beverage$645100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$645 in reported general payments places this provider in the 40th percentile of 73 gerontology providers in Oklahoma.

See all gerontology providers in Oklahoma

Medicare billing

Part B allowed, 2024
$8,366
Medicare patients
29
Services billed
113

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$23,912
OzempicSemaglutide20$20,188
Lantus SolostarInsulin Glargine,hum.Rec.Anlog52$5,369
Albuterol Sulfate HfaAlbuterol Sulfate102$2,398
Atorvastatin Calcium163$1,365
Fluticasone-SalmeterolFluticasone Propion/Salmeterol14$1,335
Gabapentin69$1,333
Omeprazole43$946
Amlodipine Besylate118$626
Megestrol Acetate14$552
Metoprolol Succinate42$359
Chlorthalidone14$264
Hydroxyzine Hcl27$262
Levothyroxine Sodium30$258
Lisinopril49$257

Paid to pharmacies, not to this prescriber.

Other gerontology in Tulsa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →